RIBOCICLIB-TABLETTE

European patent · EP4197530 · In force

Register entry

Publication number
EP4197530
Application number
EP22203730
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 14, 2016
Published
Jun 21, 2023
Granted
Nov 12, 2025
Protection ends at the latest
Apr 13, 2036
Next annual fee due
Apr 30, 2027
IPC classes
A61K 9/20 (2006.01)
Priority
US 201562148240 P 16.04.2015
Divided from
EP16718020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 19, 2026

    Change

    Published in Swissreg on 19.08.2026

  2. Aug 19, 2026

    Change

    Published in Swissreg on 19.08.2026

  3. Aug 19, 2026

    Change

    Published in Swissreg on 19.08.2026

  4. May 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.04.2026 → 30.04.2027

    Published in Swissreg on 01.05.2026

  5. Nov 12, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 12.11.2025

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

GURURAJAN, Bindhumadhavan

4002 Basel

GRANDEURY, Arnaud

4002 Basel

COSTA, Rui

4002 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.